1,7-phenanthroline has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvo, S; Bada, L; Castro, J; Diz, M; Durán-Carril, ML; García-Vázquez, JA; Viña, D | 1 |
| Chen, T; Lai, H; Li, X; Lin, H; Wang, Y | 1 |
2 other study(ies) available for 1,7-phenanthroline and Glioblastoma
| Article | Year |
|---|---|
Antitumor activity of copper(II) complexes with Schiff bases derived from N'-tosylbenzene-1,2-diamine.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Cisplatin; Coordination Complexes; Copper; Crystallography, X-Ray; Diamines; Glioblastoma; Humans; Ligands; Neuroblastoma; Phenanthrolines; Schiff Bases | 2022 |
Iron(II)-Polypyridyl Complexes Inhibit the Growth of Glioblastoma Tumor and Enhance TRAIL-Induced Cell Apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Cell Line, Tumor; Coordination Complexes; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Ferrous Compounds; Glioblastoma; Humans; Ligands; Male; Matrix Metalloproteinase 9; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Phenanthrolines; Reactive Oxygen Species; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53; Urokinase-Type Plasminogen Activator | 2018 |